NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 9 December 2009, A phase III randomised controlled trial demonstrated that darusentan reduced systolic/diastolic blood pressure by about 10/5mmHg compared with placebo in patients with treatment-resistant hypertension, but was […]
Category Archives: Cardiovascular disease
NPC Archive Item: Report considers hospital prescribing of ‘NICE appraised’ and ‘low cost’ medicines.
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 30 November 2009 The NHS Information Centre has issued a report considering expenditure on medicines in hospitals in England in 2008. It includes a table focusing on medicines positively […]
NPC Archive Item: Updated information on adverse effects of statins
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 30 November 2009 The MHRA has published a public assessment report which discusses a review of some of the adverse effects of statins. The review concluded that the following […]
NPC Archive Item: ACE inhibitors, not A2RAs or combination therapy, in ischaemic heart disease
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 12 November 2009 This systematic review found that adding an ACE inhibitor to standard medical therapy reduces the risk of certain serious CV outcomes in patients with stable ischaemic […]
NPC Archive Item: Dronedarone is less effective, but safer than amiodarone in atrial fibrillation
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 27 October 2009, An indirect comparison meta-analysis found that dronedarone was significantly less effective than amiodarone in preventing recurrence of AF, but was associated with fewer side effects requiring […]
NPC Archive Item: Dabigatran▼ vs. warfarin for prevention of stroke in atrial fibrillation: the RE-LY study
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 27 October 2009, The RE-LY study found that, in patients with atrial fibrillation with at least one other risk factor for stroke, dabigatran▼ was non-inferior to adjustable dose warfarin […]
NPC Archive Item: October Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 15 October 2009 The MHRA and CHM have published the October edition of Drug Safety Update. There is a […]
NPC Archive Item: Ticagrelor — another antiplatelet for ACS
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 2 December 2009 Ticagrelor plus aspirin was significantly more effective than clopidogrel plus aspirin in preventing vascular events in patients with acute coronary syndrome in the PLATO trial (NNT=53). […]
NPC Archive Item: New eLearning resource for VTE
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 2nd October 2009 The Chief Medical Officer’s Venous Thromboembolism (VTE) Implementation Working Group and eLearning for Healthcare have published a web-based education resource (e-VTE) designed to help raise awareness […]
NPC Archive Item: What blood pressure target in hypertension, and which drug to try first?
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 2nd October 2009 Two Cochrane reviews have addressed these questions. The review of blood pressure (BP) targets for hypertension concluded that treating patients to achieve BPs of less than […]